Tufton Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-450
| Closed | -$300K | – | 132 |
|
2021
Q4 | $300K | Hold |
450
| – | – | 0.05% | 117 |
|
2021
Q3 | $257K | Hold |
450
| – | – | 0.04% | 113 |
|
2021
Q2 | $227K | Hold |
450
| – | – | 0.04% | 120 |
|
2021
Q1 | $205K | Buy |
+450
| New | +$205K | 0.04% | 124 |
|
2020
Q4 | – | Sell |
-500
| Closed | -$220K | – | 125 |
|
2020
Q3 | $220K | Buy |
+500
| New | +$220K | 0.05% | 112 |
|
2020
Q1 | – | Sell |
-790
| Closed | -$256K | – | 118 |
|
2019
Q4 | $256K | Hold |
790
| – | – | 0.05% | 107 |
|
2019
Q3 | $230K | Hold |
790
| – | – | 0.05% | 114 |
|
2019
Q2 | $232K | Sell |
790
-60
| -7% | -$17.6K | 0.05% | 118 |
|
2019
Q1 | $232K | Buy |
+850
| New | +$232K | 0.05% | 114 |
|
2018
Q4 | – | Sell |
-850
| Closed | -$207K | – | 123 |
|
2018
Q3 | $207K | Buy |
+850
| New | +$207K | 0.04% | 118 |
|
2018
Q2 | – | Sell |
-1,500
| Closed | -$309K | – | 123 |
|
2018
Q1 | $309K | Hold |
1,500
| – | – | 0.06% | 106 |
|
2017
Q4 | $285K | Hold |
1,500
| – | – | 0.05% | 112 |
|
2017
Q3 | $284K | Hold |
1,500
| – | – | 0.06% | 109 |
|
2017
Q2 | $262K | Sell |
1,500
-15
| -1% | -$2.62K | 0.05% | 104 |
|
2017
Q1 | $233K | Buy |
+1,515
| New | +$233K | 0.05% | 111 |
|